PT Biometrik Riset Indonesia Attends Regulatory Compliance Seminar in Bandung

Writer: Verta Uli Elisda, Editor: Andi Darmawan

Bandung, Februari 20, 2025 – PT Biometrik remains committed to maintaining regulatory compliance and enhancing audit readiness in the pharmaceutical industry. As part of this effort, Mr. Andi Darmawan as Technical Manager and Ms. Oktaviani as Quality Assurance Manager of PT Biometrik, attended the Regulatory Compliance Seminar held at Hilton Bandung.

With speakers and participants Regulatory Compliance Seminar

This event was sponsored by Waters, a leading company in laboratory analysis solutions, supporting regulatory compliance advancements in the pharmaceutical sector. The seminar addressed the latest challenges in regulatory compliance and provided practical strategies for achieving audit and inspection excellence. Key topics discussed included:

✅ Recent inspection findings and how Empower features help mitigate risks while ensuring data integrity. ✅ The benefits of upgrading to the latest Empower Enterprise Software to enhance compliance and productivity. ✅ Best practices for optimizing laboratory workflows to improve audit readiness and operational efficiency. ✅ Effective strategies for Computerized System Validation (CSV) to achieve regulatory excellence.

The seminar featured presentations from industry experts, including:

• Prof. Dr. Apt. Daryono Hadi Tjahjono, M.Sc.Eng. – Professor of Pharmacochemistry, Bandung Institute of Technology
• Sandeep Balan – Sr. Manager, Expert Centre and Operational Excellence
• Kusuma – Service Consultant Manager
• Apt. Ivan Riandi Yosua Marganti Hutabarat, S.Farm – Manager Quality Assurance, PT Beta Pharmacon
• Jeevetha Mali – Principal Informatics Validation Specialist

By attending this seminar, PT Biometrik strengthens its commitment to upholding the highest standards in bioequivalence testing and pharmaceutical analysis. We believe that advancements in compliance systems and validation processes will support more reliable, efficient testing while ensuring adherence to global regulatory requirements.